14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
EVTL vs SRTA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Vertical Aerospace Ltd. (EVTL) is the stronger overall head-to-head candidate over Strata Critical Medical, Inc. (SRTA) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). EVTL carries a Unified Composite Score of 47.2/100 (HOLD) at $0.32 (6.3x Forward P/E, 0.0% operating margin), whereas SRTA carries 29.9/100 (SELL) at $5.38 (71.1x Forward P/E, -4.7% operating margin).
Technical & Structure Timing Caution: EVTL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.9); meanwhile SRTA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 54.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVTL vs SRTA. Trailing 12-month operating profitability (EVTL 0.0% vs SRTA -4.7%) and valuation multiples (EVTL 6.3x vs SRTA 71.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Care Facilities value chain with $515.4M market capitalization and -4.7% operating margin.
OpEx & R&D Reinvestment26.3% of Rev ($74M)
90D Engineering Disclosures0 Published
Investor FAQ EVTL vs SRTA Key Questions & Quantitative Answers
As of Nov 16, 2026, Vertical Aerospace Ltd. (EVTL) is the stronger overall head-to-head candidate over Strata Critical Medical, Inc. (SRTA) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). EVTL carries a Unified Composite Score of 47.2/100 (HOLD) at $0.32 (6.3x Forward P/E, 0.0% operating margin), whereas SRTA carries 29.9/100 (SELL) at $5.38 (71.1x Forward P/E, -4.7% operating margin). Technical & Structure Timing Caution: EVTL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.9); meanwhile SRTA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 54.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SRTA leads the Growth & Scale pillar: EVTL posts +73.7% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with SRTA at +50.3% YoY revenue growth and +0.0% YoY earnings growth on $281M TTM revenue (21.6% gross margin, -4.7% operating margin). On trailing 12-month operating scale, EVTL generates N/A in USD-normalized revenue versus $281M for SRTA. In operating R&D and SG&A reinvestment, EVTL deploys N/A (0 90-day corporate R&D disclosures) versus 26.3% of Rev ($74M) (0 disclosures) for SRTA.
EVTL screens cheaper on headline valuation multiples. EVTL trades at 6.3x Forward P/E, 6.3x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas SRTA trades at 71.1x Forward P/E, 138.9x Trailing P/E, N/M PEG, and 1.7x EV/Revenue (-0.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EVTL (-303.7% ROE) versus SRTA (-7.5% ROE) capital efficiency.
In options market volatility and institutional positioning, EVTL carries 131.7% implied volatility (35th %ile, Balanced (25th–60th %ile)), a 0.02x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (2.79β · 87% Vol realized risk). By comparison, SRTA carries 61.9% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.43x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.97β · 82% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.